These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
304 related articles for article (PubMed ID: 30489687)
1. Outcomes with drug-coated balloons in small-vessel coronary artery disease. Megaly M; Rofael M; Saad M; Rezq A; Kohl LP; Kalra A; Shishehbor M; Soukas P; Abbott JD; Brilakis ES Catheter Cardiovasc Interv; 2019 Apr; 93(5):E277-E286. PubMed ID: 30489687 [TBL] [Abstract][Full Text] [Related]
2. Outcomes with Drug-Coated Balloons in Percutaneous Coronary Intervention in Diabetic Patients. Megaly M; Ali A; Abraham B; Khalil C; Zordok M; Shaker M; Tawadros M; Hennawy BS; Elbadawi A; Omer M; Saad M Cardiovasc Revasc Med; 2020 Jan; 21(1):78-85. PubMed ID: 30956042 [TBL] [Abstract][Full Text] [Related]
3. Outcomes With Limus- vs Paclitaxel-Coated Balloons for Percutaneous Coronary Intervention: Meta-Analysis of Randomized Controlled Trials. Sedhom R; Hamed M; Elbadawi A; Mohsen A; Swamy P; Athar A; Bharadwaj AS; Prasad V; Elgendy IY; Alfonso F JACC Cardiovasc Interv; 2024 Jul; 17(13):1533-1543. PubMed ID: 38986653 [TBL] [Abstract][Full Text] [Related]
4. Second-generation drug-eluting stents versus drug-coated balloons for the treatment of coronary in-stent restenosis: A systematic review and meta-analysis. Kokkinidis DG; Prouse AF; Avner SJ; Lee JM; Waldo SW; Armstrong EJ Catheter Cardiovasc Interv; 2018 Aug; 92(2):285-299. PubMed ID: 29024274 [TBL] [Abstract][Full Text] [Related]
5. A propensity score matched comparative study between paclitaxel-coated balloon and everolimus-eluting stents for the treatment of small coronary vessels. Giannini F; Latib A; Ancona MB; Costopoulos C; Ruparelia N; Menozzi A; Castriota F; Micari A; Cremonesi A; De Felice F; Marchese A; Tespili M; Presbitero P; Sgueglia GA; Buffoli F; Tamburino C; Varbella F; Colombo A Catheter Cardiovasc Interv; 2017 Sep; 90(3):380-386. PubMed ID: 28109036 [TBL] [Abstract][Full Text] [Related]
6. Clinical and Angiographic Outcomes With Drug-Coated Balloons for De Novo Coronary Lesions: A Meta-Analysis of Randomized Clinical Trials. Elgendy IY; Gad MM; Elgendy AY; Mahmoud A; Mahmoud AN; Cuesta J; Rivero F; Alfonso F J Am Heart Assoc; 2020 May; 9(10):e016224. PubMed ID: 32410493 [TBL] [Abstract][Full Text] [Related]
7. The role of drug-eluting balloons alone or in combination with drug-eluting stents in the treatment of de novo diffuse coronary disease. Costopoulos C; Latib A; Naganuma T; Sticchi A; Figini F; Basavarajaiah S; Carlino M; Chieffo A; Montorfano M; Naim C; Kawaguchi M; Giannini F; Colombo A JACC Cardiovasc Interv; 2013 Nov; 6(11):1153-9. PubMed ID: 24262615 [TBL] [Abstract][Full Text] [Related]
8. Long-term efficacy of drug coated balloons compared with new generation drug-eluting stents for the treatment of de novo coronary artery lesions. Venetsanos D; Lawesson SS; Panayi G; Tödt T; Berglund U; Swahn E; Alfredsson J Catheter Cardiovasc Interv; 2018 Nov; 92(5):E317-E326. PubMed ID: 29481718 [TBL] [Abstract][Full Text] [Related]
9. Drug-coated balloons for de novo lesions in small coronary arteries: rationale and design of BASKET-SMALL 2. Gilgen N; Farah A; Scheller B; Ohlow MA; Mangner N; Weilenmann D; Wöhrle J; Jamshidi P; Leibundgut G; Möbius-Winkler S; Zweiker R; Krackhardt F; Butter C; Bruch L; Kaiser C; Hoffmann A; Rickenbacher P; Mueller C; Stephan FP; Coslovsky M; Jeger R; Clin Cardiol; 2018 May; 41(5):569-575. PubMed ID: 29527709 [TBL] [Abstract][Full Text] [Related]
10. Drug-Coated Balloons versus Everolimus-Eluting Stents in Patients with In-Stent Restenosis: A Pair-Wise Meta-Analysis of Randomized Trials. Peng N; Liu W; Li Z; Wei J; Chen X; Wang W; Lin H Cardiovasc Ther; 2020; 2020():1042329. PubMed ID: 32411298 [TBL] [Abstract][Full Text] [Related]
11. Long-Term Outcomes After Treatment With a Paclitaxel-Coated Balloon Versus Balloon Angioplasty: Insights From the PEPCAD-DES Study (Treatment of Drug-eluting Stent [DES] In-Stent Restenosis With SeQuent Please Paclitaxel-Coated Percutaneous Transluminal Coronary Angioplasty [PTCA] Catheter). Rittger H; Waliszewski M; Brachmann J; Hohenforst-Schmidt W; Ohlow M; Brugger A; Thiele H; Birkemeyer R; Kurowski V; Schlundt C; Zimmermann S; Lonke S; von Cranach M; Markovic S; Daniel WG; Achenbach S; Wöhrle J JACC Cardiovasc Interv; 2015 Nov; 8(13):1695-700. PubMed ID: 26476609 [TBL] [Abstract][Full Text] [Related]
12. Treatment of drug-eluting stent restenosis: Comparison between drug-eluting balloon versus second-generation drug-eluting stents from a retrospective observational study. Basavarajaiah S; Naganuma T; Latib A; Sticchi A; Ciconte G; Panoulas V; Chieffo A; Montorfano M; Carlino M; Colombo A Catheter Cardiovasc Interv; 2016 Oct; 88(4):522-528. PubMed ID: 26715370 [TBL] [Abstract][Full Text] [Related]
13. Drug-Coated Balloon Versus Drug-Eluting Stent for Small-Vessel Disease: The RESTORE SVD China Randomized Trial. Tang Y; Qiao S; Su X; Chen Y; Jin Z; Chen H; Xu B; Kong X; Pang W; Liu Y; Yu Z; Li X; Li H; Zhao Y; Wang Y; Li W; Tian J; Guan C; Xu B; Gao R; JACC Cardiovasc Interv; 2018 Dec; 11(23):2381-2392. PubMed ID: 30522667 [TBL] [Abstract][Full Text] [Related]
14. Comparison between drug-coated balloon angioplasty and second-generation drug-eluting stent placement for the treatment of in-stent restenosis after drug-eluting stent implantation. Kang IS; Shehata I; Shin DH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK Heart Vessels; 2016 Sep; 31(9):1405-11. PubMed ID: 26337620 [TBL] [Abstract][Full Text] [Related]
15. Drug-coated balloon angioplasty with provisional stenting versus primary stenting for the treatment of de novo coronary artery lesions: REC-CAGEFREE I trial rationale and design. Gao C; He X; Liu Y; Liu J; Jiang Z; Zhu B; Qin X; Xia Y; Zhang T; Wang P; Zhang R; Onuma Y; Xia J; Wang D; Serruys P; Tao L BMC Cardiovasc Disord; 2024 Jun; 24(1):319. PubMed ID: 38914951 [TBL] [Abstract][Full Text] [Related]
16. Long-term clinical safety and efficacy of drug-coated balloon in the treatment of in-stent restenosis: A meta-analysis and systematic review. Xi Y; Chen J; Bi Y; Xie S; Liao T; Zhang Y; Kislauskis E; Wu T; Laham R; Xiao J Catheter Cardiovasc Interv; 2020 Aug; 96(2):E129-E141. PubMed ID: 31714010 [TBL] [Abstract][Full Text] [Related]
17. The efficacy and safety of drug-eluting balloons for the treatment of in-stent restenosis as compared with drug-eluting stents and with conventional balloon angioplasty. Oh PC; Suh SY; Kang WC; Lee K; Han SH; Ahn T; Shin EK Korean J Intern Med; 2016 May; 31(3):501-6. PubMed ID: 26951915 [TBL] [Abstract][Full Text] [Related]
18. 3-Year Clinical Follow-Up of the RIBS IV Clinical Trial: A Prospective Randomized Study of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients With In-Stent Restenosis in Coronary Arteries Previously Treated With Drug-Eluting Stents. Alfonso F; Pérez-Vizcayno MJ; Cuesta J; García Del Blanco B; García-Touchard A; López-Mínguez JR; Masotti M; Zueco J; Cequier A; Velázquez M; Moreno R; Mainar V; Domínguez A; Moris C; Molina E; Rivero F; Jiménez-Quevedo P; Gonzalo N; Fernández-Pérez C; JACC Cardiovasc Interv; 2018 May; 11(10):981-991. PubMed ID: 29798776 [TBL] [Abstract][Full Text] [Related]
19. Comparison of clinical outcomes of two different types of paclitaxel-coated balloons for treatment of patients with coronary in-stent restenosis. Nguyen VPT; Kim C; Hong SJ; Ahn CM; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK Heart Vessels; 2019 Sep; 34(9):1420-1428. PubMed ID: 30903315 [TBL] [Abstract][Full Text] [Related]
20. Outcomes With Drug-Coated Balloons vs. Drug-Eluting Stents in Small-Vessel Coronary Artery Disease. Megaly M; Buda K; Saad M; Tawadros M; Elbadawi A; Basir M; Abbott JD; Rinfret S; Alaswad K; Brilakis ES Cardiovasc Revasc Med; 2022 Feb; 35():76-82. PubMed ID: 33858783 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]